Saturday, October 31, 2026

Rumble Stock Plummets 12.6% In Pre-Market Trading

ViaNews Editorial Team

January 24, 2024

Rumble Stock Plummets 12.6% In Pre-Market Trading

(VIANEWS) - Investors were swift in their negative responses to Rumble (NASDAQ: RUM), with shares plunging by 12.15% to close at EUR5.71 at 12:44 EST on Wednesday despite Rumble having been on an upward trend for five consecutive sessions prior to this drop. Although NASDAQ overall rose 1.11% and EUR15,597.09 saw positive gains, Rumble's performance stood out; with shares now sitting 42.22% below its 52-week high of EUR11.25.

About Rumble

Rumble Inc. is a video sharing platform operating across the US, Canada and internationally. They offer three services that comprise their comprehensive suite: Rumble.com, Locals.com and Rumble Advertising Center (RAC). Rumble allows users to subscribe to channels so that they can view video on-demand and live content streamed by creators; Locals provides creators and subscribers an engagement platform featuring VOD content, podcasts, live chat sessions polls and community discussions; while RAC serves advertisers by connecting them effectively with their target audiences effectively; Rumble was founded in 2013 with headquarters located in Longboat Key Florida.

Yearly Analysis

According to current data, Rumble's stock (RYMB.SG) is currently trading at EUR5.71, significantly below its 52-week high of EUR11.25 but higher than its 52-week low of EUR3.33. Rumble's anticipated sales growth projection is anticipated to experience an astounding spike of 125.2% this year; its projected rate for next year should increase further to 106.55%. Rumble's EBITDA, which measures its profitability, stands at -28.51; this indicates that Rumble is incurring losses and does not generate enough profits to cover its expenses. Investors should exercise extreme caution when investing in companies with negative EBITDAs; prioritising analysis of financials and growth potential when making investment decisions.

Technical Analysis

Rumble (RUM), a media and entertainment company, saw its stock price decrease significantly on May 9, 2023 due to fluctuations in recent days. RUM currently trades below its 50-day moving average of EUR4.55 and far below its 200-day moving average of EUR7.02. Trading volume for Rumble has significantly exceeded its 50-day average volume of 3,173,600, reaching 21,611,632 today - an increase of 589.98% over its 50-day average volume of 3,173,600. This indicates increased investor enthusiasm and activity within this stock. Rumble stock has experienced moderate volatility over the past week, with an intraday variation average of 11.88%. Volatility was lower during last month and quarter, at an average of 0.33% and 4.29%, respectively. Rumble's highest amplitude of average volatility occurred over last week at 14.57% versus 6.65% vs 4.39% during previous month/quarter periods. According to the stochastic oscillator, a popular indicator used to spot overbought and oversold conditions, Rumble's stock may currently be considered oversold (=20). This indicates that its valuation may have fallen too far below market standards and investors could view it as an opportunity to purchase. Overall, Rumble's stock has experienced a steep drop, trading below both short-term and long-term moving averages. Yet its increased trading volume may signal potential buying opportunities for investors.

Quarter Analysis

Rumble's sales growth for this quarter has surged 41%, reflecting an impressively rapid increase in demand for their products or services. This growth rate surpasses industry norms by an astounding margin, suggesting Rumble is outpacing competition in its industry. Looking ahead, expected growth for next quarter should reach 27.6% indicating continued momentum at Rumble and could attract investors as such strong sales growth is often considered an indicator of future profitability. Rumble's year-on-year quarterly revenue growth over the past twelve months stands out, reflecting their ability to generate substantial revenues from operations. Their current annualized revenue stands at 80.53M and their business strategy appears to be working. Investors should take note that growth alone does not always translate to profitability; investors should also look at other financial metrics such as gross margin and net income when evaluating Rumble's overall financial health.

Equity Analysis

Earnings Per ShareRumble's trailing 12-month EPS stands at EUR-0.42, reflecting negative earnings. Their Return on Equity stands at -28.68% for this period, suggesting their performance remains negative over time. Investors should note that negative earnings and low return on equity could signal financial challenges within a company that could hinder its ability to pay dividends or distribute profits back to shareholders. Before making investment decisions, it is crucial to carefully consider these and other financial indicators before taking a position on Rumble. Given its current negative earnings and low return on equity figures, investors may wish to proceed with caution before investing.

More news about Rumble (RUM).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com